Testing effectiveness (Phase 2)Ended earlyNCT06005974
What this trial is testing
REC-4881 in Participants With Cancers Which Have an AXIN1 or APC Mutation
Who this might be right for
AXIN1 Gene MutationAPC Gene MutationSolid Tumor
Recursion Pharmaceuticals Inc. 18